Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARTLNASDAQ:AYTUNASDAQ:BLRXNASDAQ:HCWB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARTLArtelo Biosciences$1.07+5.9%$0.97$0.82▼$1.55$3.51M1.03136,472 shs281,132 shsAYTUAytu BioPharma$1.78-2.7%$1.35$0.95▼$3.23$10.98M-0.1323,641 shs128,196 shsBLRXBioLineRx$5.44+43.5%$3.16$2.30▼$35.60$18.11M1.15214,135 shs36.47 million shsHCWBHCW Biologics$7.90-1.5%$8.53$5.00▼$100.80$11.37M0.85260,923 shs240,371 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARTLArtelo Biosciences0.00%+12.31%+4.90%+7.00%-21.90%AYTUAytu BioPharma0.00%-9.18%+35.89%+41.27%-43.49%BLRXBioLineRx0.00%+48.63%+58.14%+72.15%-81.76%HCWBHCW Biologics0.00%-5.62%+3.54%-48.03%-81.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARTLArtelo Biosciences3.1456 of 5 stars3.84.00.00.03.30.01.3AYTUAytu BioPharma0.8965 of 5 stars0.02.00.03.43.00.00.6BLRXBioLineRx3.1325 of 5 stars3.84.00.00.03.20.01.3HCWBHCW Biologics2.1475 of 5 stars3.52.00.00.01.63.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARTLArtelo Biosciences 3.50Strong Buy$5.50414.02% UpsideAYTUAytu BioPharma 0.00N/AN/AN/ABLRXBioLineRx 3.50Strong Buy$26.00377.94% UpsideHCWBHCW Biologics 3.00Buy$35.00343.04% UpsideCurrent Analyst Ratings BreakdownLatest ARTL, BLRX, AYTU, and HCWB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025BLRXBioLineRxJones TradingSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/29/2025HCWBHCW BiologicsMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$120.00 ➝ $35.005/28/2025BLRXBioLineRxHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy4/28/2025ARTLArtelo BiosciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.004/2/2025ARTLArtelo BiosciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.004/2/2025BLRXBioLineRxJones TradingSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold3/31/2025BLRXBioLineRxHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$9.00 ➝ $26.003/4/2025ARTLArtelo BiosciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARTLArtelo BiosciencesN/AN/AN/AN/A$4.12 per shareN/AAYTUAytu BioPharma$81.66M0.13N/AN/A$4.64 per share0.38BLRXBioLineRx$22.34M0.81N/AN/A$7.30 per share0.75HCWBHCW Biologics$1.45M7.87N/AN/A$0.37 per share21.35Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARTLArtelo Biosciences-$9.29M-$2.99N/AN/AN/AN/A-104.59%-94.06%8/12/2025 (Estimated)AYTUAytu BioPharma-$15.84M-$0.72N/A∞N/A-7.62%-19.30%-4.80%N/ABLRXBioLineRx-$60.61M-$8.80N/AN/AN/A-90.57%-163.37%-34.21%8/14/2025 (Estimated)HCWBHCW Biologics-$24.99M-$23.25N/A∞N/A-1,067.82%-2,516.84%-132.95%N/ALatest ARTL, BLRX, AYTU, and HCWB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/27/2025Q1 2025BLRXBioLineRx-$0.84$1.39+$2.23$1.39$7.72 million$11.75 million5/15/2025Q1 2025HCWBHCW BiologicsN/A-$0.05N/A-$0.05N/AN/A5/14/2025Q3 2025AYTUAytu BioPharma-$0.17$0.20+$0.37$0.21$13.74 million$18.45 million5/13/2025Q1 2025ARTLArtelo Biosciences-$0.13-$0.72-$0.59-$0.72N/AN/A3/28/2025Q4 2024HCWBHCW BiologicsN/A-$3.20N/A-$0.08N/A$0.40 million3/3/2025Q4 2024ARTLArtelo Biosciences-$0.74-$1.17-$0.43-$1.17N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARTLArtelo BiosciencesN/AN/AN/AN/AN/AAYTUAytu BioPharmaN/AN/AN/AN/AN/ABLRXBioLineRxN/AN/AN/AN/AN/AHCWBHCW BiologicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARTLArtelo BiosciencesN/A7.157.15AYTUAytu BioPharma0.320.980.81BLRXBioLineRx2.111.521.37HCWBHCW BiologicsN/A0.070.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARTLArtelo Biosciences0.87%AYTUAytu BioPharma33.49%BLRXBioLineRx1.56%HCWBHCW Biologics2.96%Insider OwnershipCompanyInsider OwnershipARTLArtelo Biosciences0.83%AYTUAytu BioPharma3.60%BLRXBioLineRx1.10%HCWBHCW Biologics49.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARTLArtelo Biosciences53.28 million3.20 millionNot OptionableAYTUAytu BioPharma1606.17 million6.00 millionNot OptionableBLRXBioLineRx403.33 million3.29 millionOptionableHCWBHCW Biologics401.44 million22.32 millionNot OptionableARTL, BLRX, AYTU, and HCWB HeadlinesRecent News About These CompaniesMaxim Group Has Lowered Expectations for HCW Biologics (NASDAQ:HCWB) Stock PriceMay 30 at 3:09 AM | americanbankingnews.comHCW Biologics Inc.: HCW Biologics Reports First Quarter 2025 Business Highlights and Financial ResultsMay 16, 2025 | finanznachrichten.deHCW Biologics clings on with $5M lifeline to fund phase 1 alopecia trialMay 16, 2025 | fiercebiotech.comHCW Biologics presents novel CAR-T cell enhancerMay 15, 2025 | uk.investing.comHCW Biologics Inc. Unveils Innovative HCW9206 Fusion Protein at AAI 2025, Promising Enhanced CAR-T Therapy Efficacy and Cost ReductionMay 15, 2025 | nasdaq.comHCW Biologics Reports Positive Results For HCW9206 And Opens Commercial Partnership TalksMay 15, 2025 | nasdaq.comHCW Biologics, Inc.May 15, 2025 | cnn.comHCW Biologics Reports First Quarter 2025 Business Highlights and Financial ResultsMay 15, 2025 | finance.yahoo.comHCW Biologics Inc. Reports Q1 2025 Financial Results and $5 Million Equity Offering CompletionMay 15, 2025 | quiverquant.comHCW Biologics Reports First Quarter 2025 Business Highlights and Financial ResultsMay 15, 2025 | globenewswire.comHCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ RulesMay 13, 2025 | finance.yahoo.comHCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ RulesMay 13, 2025 | globenewswire.comHCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for CommercializationMay 13, 2025 | globenewswire.comLee Flowers Buys 962 Shares of HCW Biologics Inc. (NASDAQ:HCWB) StockMay 10, 2025 | insidertrades.comHCW Biologics faces lawsuit over construction contract breachApril 24, 2025 | investing.comHcw Biologics Inc trading halted, news pendingApril 11, 2025 | markets.businessinsider.comHCW Biologics files to sell 7.1M shares of common stock for holdersApril 8, 2025 | markets.businessinsider.comHCW Biologics approves reverse stock split to meet Nasdaq rulesApril 3, 2025 | investing.comHCW Biologics approves 1-for-40 reverse stock splitApril 2, 2025 | markets.businessinsider.comHCW Biologics Announces 1-for-40 Reverse Stock SplitApril 1, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeARTL, BLRX, AYTU, and HCWB Company DescriptionsArtelo Biosciences NASDAQ:ARTL$1.07 +0.06 (+5.94%) Closing price 05/30/2025 03:59 PM EasternExtended Trading$1.10 +0.03 (+2.71%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.Aytu BioPharma NASDAQ:AYTU$1.78 -0.05 (-2.73%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$1.91 +0.13 (+7.30%) As of 08:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.BioLineRx NASDAQ:BLRX$5.44 +1.65 (+43.54%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$4.72 -0.73 (-13.33%) As of 08:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.HCW Biologics NASDAQ:HCWB$7.90 -0.12 (-1.50%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$7.73 -0.17 (-2.15%) As of 08:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet Nike’s Amazon Expansion Could Signal a Turnaround in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
